Ipsen S.A.
EPA:IPN.PA
Overview | Financials
Company Name | Ipsen S.A. |
Symbol | IPN.PA |
Currency | EUR |
Price | 116.8 |
Market Cap | 9,652,260,312 |
Dividend Yield | 0.99% |
52-week-range | 99.7 - 126.7 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. David Loew |
Website | https://www.ipsen.com |
An error occurred while fetching data.
About Ipsen S.A.
Ipsen S.A. operates as a biopharmaceutical company worldwide. The company provides drugs in the areas of oncology, neuroscience, gastroenterology, cognitive disorders, and rare diseases. It offers Somatuline for neuroendocrine tumors and acromegaly; Decapeptyl for the treatment of advanced metastatic prostate cancer; Cabometyx for renal cell and second-line hepatocellular carcinoma; Onivyde
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD